Penserra Capital Management LLC Cooper Companies, Inc. Transaction History

Penserra Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$306.88 - $380.0 $14,730 - $18,240	-48 Reduced 17.33%	229 $86,000
Q3 2023 Nov 15, 2023	SELL	$315.92 - $397.36 $14,216 - $17,881	-45 Reduced 13.98%	277 $87,000
Q2 2023 Aug 11, 2023	BUY	$346.15 - $392.09 $110,768 - $125,468	320 Added 16000.0%	322 $122,000
Q1 2023 Apr 24, 2023	BUY	$323.56 - $373.36 $647 - $746	2 New	2 $0
Q4 2018 Feb 06, 2019	SELL	$232.7 - $281.66 $363,942 - $440,516	-1,564 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$236.3 - $277.15 $52,222 - $61,250	221 Added 16.46%	1,564 $433,000
Q2 2018 Aug 13, 2018	BUY	$217.98 - $237.23 $11,116 - $12,098	51 Added 3.95%	1,343 $316,000
Q1 2018 May 08, 2018	BUY	$218.74 - $251.43 $22,311 - $25,645	102 Added 8.57%	1,292 $295,000
Q4 2017 Feb 07, 2018	BUY	$217.88 - $244.43 $40,743 - $45,708	187 Added 18.64%	1,190 $259,000
Q3 2017 Oct 26, 2017	BUY	$231.6 - $253.39 $27,560 - $30,153	119 Added 13.46%	1,003 $241,000
Q2 2017 Aug 21, 2017	BUY	N/A	884	884 $211,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.